Back

Gender differences in hypertrophic cardiomyopathy assessed by cardiovascular magnetic resonance feature tracking

25 April 2024 (12:45 - 13:45)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: diagnosis and management Epidemiology, Prognosis, Outcome Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Raluca Tomoaia

Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca (Romania)

10 More presentations in this session

Presentation thumbnail
Angiotensin II receptor blockers is associated a decreased left ventricular fibrosis in patients with obstructive hypertrophic cardiomyopathy
Doctor C. Nie (Beijing, CN)
Abstract Slides
Presentation thumbnail
Are patients with hypertrophic cardiomyopathy given appropriate advice on exercise at a central London inherited cardiac conditions outpatient service?
Doctor K. Sonthikaew (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Cardiac magnetic resonance imaging aids in differentiating dilated cardiomyopathy from the athlete's heart
Mr J. Daems (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Optimising screening of intermediate to high-risk asymptomatic sportsmen with exercise electrocardiogram.
Doctor D. Hupin (Saint-Etienne, FR)
Abstract Slides
Presentation thumbnail
Cardiopulmonary exercise testing in athletes and non-athletes with hypertrophic cardiomyopathy
Doctor J. Scicluna (Msida, MT)
Abstract Slides

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: diagnosis and management

The Event

Event poster

ESC Preventive Cardiology 2024

25 April 2024 12:45 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources